We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study (INCREMENT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01764490
Recruitment Status : Completed
First Posted : January 9, 2013
Last Update Posted : June 27, 2014
Information provided by (Responsible Party):
JESUS RODRIGUEZ BAÑO, Spanish Network for Research in Infectious Diseases

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2013
Actual Study Completion Date : May 2014
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):